Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fine Chemicals. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114591348A reveals a mild Cs2CO3-catalyzed route for benzothienopyrrole synthesis. Discover cost-effective manufacturing and high-yield scalability for pharma intermediates.
Patent CN105622544A details a one-step Rh-catalyzed route to N-sulfonyl-3,4-dihydro-2H-1,4-thiazine, offering streamlined manufacturing and high purity for pharmaceutical intermediates.
Patent CN1628087A reveals a novel onium salt catalyzed route for alkenone synthesis, offering superior yield and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111187160A details a green aqueous synthesis of esters using carboxylic acids and enones, offering significant cost reduction and high purity for pharmaceutical intermediates manufacturing.
Discover a scalable synthesis route for chiral binaphthalene dicarboxylic acid via patent CN101781197A. Achieve >99% optical purity and significant cost reduction in pharma intermediate manufacturing.
Patent CN106938983B reveals nickel-catalyzed olefin synthesis. Achieve cost reduction in fine chemical manufacturing with high-purity intermediates and scalable processes.
Patent CN114591185B introduces a green iridium-catalyzed method for amino alcohol synthesis using ethylene glycol, offering high selectivity and supply chain advantages.
Patent CN114773185B reveals a copper-catalyzed deoxyfluorination method. Offers cost-effective, scalable production of high-purity benzoyl fluoride intermediates for pharma.
Patent CN111848508A details a green catalytic oxidation method for quinolines using copper and oxygen, offering cost-effective and scalable solutions for pharmaceutical intermediates.
Patent CN108658815A reveals a copper-catalyzed synthesis for amino-substituted conjugated enyne aldehydes, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN105755095A enables high-yield enzymatic deracemization. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN113355367B reveals high-efficiency LlKAR enzyme for deracemization. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111004176A reveals a green cobalt-catalyzed route for 2-aryloxy ethanol compounds, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Novel ionic liquid method for cyclopentanone production offering high selectivity and catalyst recycling for fine chemical supply chains.
Patent CN114394913B introduces a metal-free heteropolyacid catalyzed synthesis of oxime ethers. This method offers significant cost reduction and environmental benefits for pharmaceutical intermediate manufacturing.
Patent CN105112468A reveals multi-enzyme systems for chiral amine synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable biocatalysis.
Novel biomass-derived route for 4-methylbenzaldehyde using ionic liquids and graphite oxide catalysts ensures cost reduction and supply chain reliability for global buyers.
Patent CN102060800B details a novel BTC-based synthesis eliminating phosphorus waste. Discover cost-effective manufacturing and high-purity supply solutions.
Novel [5+6] cycloaddition method for azacyclolactones offers high yields and mild conditions, ensuring reliable supply and cost efficiency for pharmaceutical manufacturing.
Patent CN111320644B reveals a mild, high-yield hydroboration method using commercial n-butyllithium, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.